About Sermorelin
Sermorelin is a synthetic GHRH (1-29) analogue used in endocrine research. Supplied as a lyophilized powder for laboratory investigations into physiological GH secretion mechanisms and pituitary signaling pathways in controlled experimental models. Each batch undergoes analytical verification for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at ?20�C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.
Latest Research
Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation.
Recent research on Sermorelin: Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation.
Read Full Study on PubMedCardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of growth hormone-releasing hormone.
Recent research on Sermorelin: Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of growth hormone-releasing hormone.
Read Full Study on PubMedAdditional Studies
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.
Recent research on Sermorelin: A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.
Read on PubMedAnalysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.
Recent research on Sermorelin: Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.
Read on PubMedAnterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report.
Recent research on Sermorelin: Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report.
Read on PubMedTherapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Recent research on Sermorelin: Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Read on PubMedGrowth hormone - releasing hormone antagonists induce autophagy in cancer cells.
Recent research on Sermorelin: Growth hormone - releasing hormone antagonists induce autophagy in cancer cells.
Read on PubMedRelated Research
Purchase Sermorelin from Origin Peptides
High-purity research peptides with full analytical verification
- 99% Purity (HPLC Verified)
- Full Certificate of Analysis
- Same Day Dispatch
- Free UK Shipping Over £75
Research Disclaimer
The research articles and studies referenced on this page are for informational purposes only. All products are sold for research use only and are not intended for human or animal consumption. The information provided does not constitute medical advice, diagnosis, or treatment. Always consult with qualified healthcare professionals before making any decisions related to health or medical treatment.